PC5513 - Pharmaceutical Public Health - Management of Chronic Diseases 1
Credit points: | 03 |
Year: | 2016 |
Student Contribution Band: | Band 2 |
Administered by: | College of Medicine & Dentistry |
Pharmaceutical Public Health is a developing specialty which seeks to influence pharmaceutical health determinants on a population basis, rather than having a focus on the individual patient. However, in the implementation of pharmaceutical public health services it is still important for pharmacists to possess a current knowledge of the clinical management of key disease states. This is one of a series of subjects that review both the clinical management and the pharmaceutical public health issues associated with a range of key disease states. This subject focusses on three health problems that are prevalent in the developing world but which also have major implications or concerns for the developed world: HIV/AIDS, Malaria and Tuberculosis. The subject introduces the student to the pharmaceutcial public health issues associated with these diseases and some clinical management issues. it also introduces the student to the health activities of the UN Global Fund.
Learning Outcomes
- demonstrate a mastery and understanding of a body of theoretical knowledge relating to a number of pharmacuetical public health priority areas including principally; HIV/AIDS, Tuberculosis and Malaria in both developed and developing countries;
- demonstrate an ability to critically analyse and/or adapt, construct and develop strategies and guidelines to promote and optimise the provision of ethically and culturally appropriate pharmaceutical public health services in a number of pharmaceutical public health priority areas including principally; HIV/AIDS, Tuberculosis and Malaria in both developed and developing countries;
- demonstrate an ability to critically analyse, review, evaluate and develop strategies for the enhancement of the role of pharmacists and pharmacies in the provision of services in a number of pharmaceutical public health priority areas including principally; HIV/AIDS, Tuberculosis and Malaria in both developed and developing countries;
- demonstrate an ability to interpret and accurately and appropriately communicate and disseminate a broad range of theoretical and actual pharmaceutical public health concepts, chiefly in the areas of HIV/AIDS, Tuberculosis and Malaria to both specialist and non- specialist audiences.
Availabilities | |
External, Study Period 1 | |
Census Date 24-Mar-2016 | |
Coord/Lect: | Assoc. Professor Ian Heslop. |
Method of Delivery: | WWW - LearnJCU and Printed materials |
Assessment: | end of semester exam (40%); assignments (60%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.